Investor Expectations to Drive Momentum within CVS Health, KKR & Co., ConocoPhillips, MetLife, Rockwell Automation, and Norfolk Southern — Discovering Underlying Factors of Influence

25-03-2019

NEW YORK, March 25, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of CVS Health Corporation (NYSE:CVS), KKR & Co. Inc. (NYSE:KKR), ConocoPhillips (NYSE:COP), MetLife, Inc. (NYSE:MET), Rockwell Automation, Inc. (NYSE:ROK), and Norfolk Southern Corporation (NYSE:NSC), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

CVS DOWNLOAD: https://Capital-Review.com/register/?so=CVS
KKR DOWNLOAD: https://Capital-Review.com/register/?so=KKR
COP DOWNLOAD: https://Capital-Review.com/register/?so=COP
MET DOWNLOAD: https://Capital-Review.com/register/?so=MET
ROK DOWNLOAD: https://Capital-Review.com/register/?so=ROK
NSC DOWNLOAD: https://Capital-Review.com/register/?so=NSC

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Capital Review, available for free download at the links above, examine CVS Health Corporation (NYSE:CVS), KKR & Co. Inc. (NYSE:KKR), ConocoPhillips (NYSE:COP), MetLife, Inc. (NYSE:MET), Rockwell Automation, Inc. (NYSE:ROK), and Norfolk Southern Corporation (NYSE:NSC) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 22nd, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

CVS HEALTH CORPORATION (CVS) REPORT OVERVIEW

CVS Health's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, CVS Health reported revenue of $54,909.00MM vs $48,406.00MM (up 13.43%) and analysts estimated basic earnings per share -$0.39 vs $3.22. For the twelve months ended December 31st, 2018 vs December 31st, 2017, CVS Health reported revenue of $194,579.00MM vs $184,786.00MM (up 5.30%) and analysts estimated basic earnings per share -$0.57 vs $6.47. Analysts expect earnings to be released on May 1st, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $1.48. The estimated EPS forecast for the next fiscal year is $7.31 and is expected to report on February 19th, 2020.

To read the full CVS Health Corporation (CVS) report, download it here: https://Capital-Review.com/register/?so=CVS

-----------------------------------------

KKR & CO. INC. (KKR) REPORT OVERVIEW

KKR & Co.'s Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, KKR & Co. reported revenue of -$178.06MM vs $1,024.07MM and analysts estimated basic earnings per share -$0.77 vs $0.33. For the twelve months ended December 31st, 2018 vs December 31st, 2017, KKR & Co. reported revenue of $2,395.84MM vs $3,557.28MM (down 32.65%) and analysts estimated basic earnings per share $2.14 vs $2.10 (up 1.90%). Analysts expect earnings to be released on May 2nd, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.42. The estimated EPS forecast for the next fiscal year is $1.95 and is expected to report on February 7th, 2020.

To read the full KKR & Co. Inc. (KKR) report, download it here: https://Capital-Review.com/register/?so=KKR

-----------------------------------------

CONOCOPHILLIPS (COP) REPORT OVERVIEW

ConocoPhillips' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, ConocoPhillips reported revenue of $10,361.00MM vs $8,736.00MM (up 18.60%) and analysts estimated basic earnings per share $1.61 vs $1.26 (up 27.78%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, ConocoPhillips reported revenue of $38,727.00MM vs $32,584.00MM (up 18.85%) and analysts estimated basic earnings per share $5.36 vs -$0.70. Analysts expect earnings to be released on April 25th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.96. The estimated EPS forecast for the next fiscal year is $3.77 and is expected to report on January 30th, 2020.

To read the full ConocoPhillips (COP) report, download it here: https://Capital-Review.com/register/?so=COP

-----------------------------------------

METLIFE, INC. (MET) REPORT OVERVIEW

MetLife's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, MetLife reported revenue of $15,662.00MM vs $15,840.00MM (down 1.12%) and basic earnings per share $2.03 vs $2.13 (down 4.69%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, MetLife reported revenue of $67,941.00MM vs $62,308.00MM (up 9.04%) and analysts estimated basic earnings per share $4.95 vs $3.65 (up 35.62%). Analysts expect earnings to be released on May 1st, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $1.36. The estimated EPS forecast for the next fiscal year is $6.06 and is expected to report on February 5th, 2020.

To read the full MetLife, Inc. (MET) report, download it here: https://Capital-Review.com/register/?so=MET

-----------------------------------------

ROCKWELL AUTOMATION, INC. (ROK) REPORT OVERVIEW

Rockwell Automation's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Rockwell Automation reported revenue of $1,642.30MM vs $1,586.60MM (up 3.51%) and analysts estimated basic earnings per share $0.67 vs -$1.84. For the twelve months ended September 30th, 2018 vs September 30th, 2017, Rockwell Automation reported revenue of $6,666.00MM vs $6,311.30MM (up 5.62%) and analysts estimated basic earnings per share $4.27 vs $6.42 (down 33.49%). Analysts expect earnings to be released on April 24th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $1.89. The estimated EPS forecast for the next fiscal year is $9.78 and is expected to report on November 6th, 2019.

To read the full Rockwell Automation, Inc. (ROK) report, download it here: https://Capital-Review.com/register/?so=ROK

-----------------------------------------

NORFOLK SOUTHERN CORPORATION (NSC) REPORT OVERVIEW

Norfolk Southern's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Norfolk Southern reported revenue of $2,896.00MM vs $2,669.00MM (up 8.51%) and analysts estimated basic earnings per share $2.58 vs $13.79 (down 81.29%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Norfolk Southern reported revenue of $11,458.00MM vs $10,551.00MM (up 8.60%) and analysts estimated basic earnings per share $9.58 vs $18.76 (down 48.93%). Analysts expect earnings to be released on April 24th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $1.93. The estimated EPS forecast for the next fiscal year is $11.90 and is expected to report on January 23rd, 2020.

To read the full Norfolk Southern Corporation (NSC) report, download it here: https://Capital-Review.com/register/?so=NSC

-----------------------------------------

ABOUT CAPITAL REVIEW

Capital Review is a nationally recognized publisher of financial analysis, research reports, and exclusive market reporting. Institutional investors, registered brokers, professional traders, and personal investment advisers rely on Capital Review to quantify public company valuations, discover opportunity across asset classes, stay informed about market-moving events, and read exclusive analysis of important material developments. With 14 offices worldwide, Capital Review staffs and manages certified and registered financial professionals, including Chartered Financial Analyst® (CFA®) designation holders and FINRA® BrokerCheck® certified individuals with current and valid CRD® number designations, to enable continuous coverage of topics relevant to its regular active reader base.

REGISTERED MEMBER STATUS

Capital Review's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Capital Review's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Capital Review have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Capital Review's Compliance department by Phone, at +1 (410) 280-7496, or by E-mail at compliance@Capital-Review.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Capital Review, Capital Review members, and/or Capital Review affiliates are not responsible for any gains or losses that result from the opinions expressed. Capital Review makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Capital Review has not been compensated for the publication of this press release by any of the above mentioned companies. Capital Review is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Nicole Garrens, Media Department
Office: +1 (410) 280-7496
E-mail: media@Capital-Review.com 

© 2019 Capital Review. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Capital-Review.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Latest news
Related news
Related shares
CVS Health Corporation
VOL 2,257,715
61.65 USD
0.09 / 0.15 %

ConocoPhillips
VOL 2,001,583
52.63 USD
-0.08 / -0.15 %

MetLife Inc
VOL 1,279,568
45.76 USD
0.39 / 0.86 %

KKR & Co L.P. Common Unit
VOL 694,446
25.70 USD
0.77 / 3.09 %

Norfolk Southern Corporation
VOL 234,863
174.20 USD
2.38 / 1.39 %

Rockwell Automation Inc
VOL 109,514
151.88 USD
1.18 / 0.78 %